Differences in activated clotting time and initial heparin dosage during atrial fibrillation ablation for patients with edoxaban compared with warfarin

Author:

Yamaji Hirosuke1ORCID,Murakami Takashi1,Hina Kazuyoshi1,Higashiya Shunichi1,Kawamura Hiroshi1,Murakami Masaaki1,Kamikawa Shigeshi1,Hirohata Satoshi2,Kusachi Shozo12

Affiliation:

1. Heart Rhythm Center; Okayama Heart Clinic; 54-1, Takeda, Naka Ward Okayama 703-8251 Okayama Japan

2. Department of Medical Technology; Okayama University Graduate School of Health Sciences; 2-5-1, Shikata-cho, Kita-ku Okayama 700-8558 Okayma Japan

Publisher

Wiley

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Reference29 articles.

1. Oral anticoagulant use around the time of atrial fibrillation ablation: A review of the current evidence of individual oral anticoagulant use for periprocedural atrial fibrillation ablation thromboembolic prophylaxis;Garton;J Cardiovasc Electrophysiol,2014

2. New oral anticoagulants in patients with nonvalvular atrial fibrillation: A review of pharmacokinetics, safety, efficacy, quality of life, and cost effectiveness;Mani;Drug Des Devel Ther,2014

3. Efficacy and safety of the novel oral anticoagulants in atrial fibrillation: A systematic review and meta-analysis of the literature;Dentali;Circulation,2012

4. Edoxaban versus warfarin in patients with atrial fibrillation;Giugliano;N Engl J Med,2013

5. Clinical safety, tolerability, pharmacokinetics, and pharmacodynamics of the novel factor Xa inhibitor edoxaban in healthy volunteers;Ogata;J Clin Pharmacol,2010

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3